Rivaroxaban
Who holds supplier records for Rivaroxaban? 82 organisations hold a current record for Rivaroxaban: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 62 of them hold a valid EU Certificate of Suitability (61 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (46), China (15), Spain (3), Germany (1) and 9 other countries (9); not recorded for 8.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Rivaroxaban: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/rivaroxaban
Reading the evidence
- 82 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
46 of the 74 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 39 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Rivaroxaban expires 6 Aug 2044. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (82)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Rivaroxaban. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 41609, 28121 · latest filing Dec 2025
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 28056 · latest filing Mar 2014
- ALIVUS LIFE SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 28864 · latest filing Jan 2015
- AMI LIFESCIENCES PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 37173 · latest filing Jun 2022
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 29048 · latest filing Feb 2015
- Bayer AGGermanyCEP Company GMP cert on recordActive DMF 21581 · latest filing Jul 2008
- Biocon LimitedIndiaCEPActive DMF 35387 · latest filing Dec 2020
- CHANGZHOU PHARMACEUTICAL FACTORYChinaCEP Company GMP cert on recordActive DMF 34436 · latest filing Dec 2019
- CHIERON ACTIVE INGREDIENTS PRIVATE LTDIndiaCEPActive DMF 42017 · latest filing Jul 2025
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 35649 · latest filing Apr 2021
- COHANCE LIFESCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 32115 · latest filing Oct 2017
- Divis LaboratoriesIndiaCEP Company GMP cert on recordActive DMF 40060 · latest filing Sept 2024
- GOLD PHARMA PRIVATE LIMITEDIndiaCEPActive DMF 44041 · latest filing Apr 2026
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 38061 · latest filing Feb 2023
- HIKAL LTDIndiaCEP Company GMP cert on recordActive DMF 38708 · latest filing Aug 2023
- INDOCO REMEDIES LTDIndiaCEP Company GMP cert on recordActive DMF 37570 · latest filing Nov 2022
- INNOVARE LABS PRIVATE LTDIndiaCEPActive DMF 35820 · latest filing Mar 2021
- Jiangxi Synergy Pharmaceutical Co., LtdChinaCEPActive DMF 31601 · latest filing Mar 2017
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 31381 · latest filing Mar 2017
- LEE PHARMA LTDIndiaCEP Company GMP cert on recordActive DMF 36672 · latest filing Jun 2022
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 34226 · latest filing Oct 2019
- MEDICHEM MANUFACTURING (MALTA) LTDMaltaCEP Company GMP cert on recordActive DMF 28916 · latest filing Dec 2014
- MEGAFINE PHARMA P LTDIndiaCEPActive DMF 28927 · latest filing Dec 2014
- MICRO LABS LTDIndiaCEP Company GMP cert on recordActive DMF 31418 · latest filing Mar 2017
- MOREPEN LABORATORIES LTDIndiaCEP Company GMP cert on recordActive DMF 36252 · latest filing Aug 2021
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 27807 · latest filing Dec 2013
- Neuland Laboratories LimitedIndiaCEPActive DMF 30609 · latest filing Sept 2016
- OPTIMUS DRUGS PRIVATE LTDIndiaCEPActive DMF 32846 · latest filing Feb 2019
- QUIMICA SINTETICA SASpainCEP Company GMP cert on recordActive DMF 39227 · latest filing Jan 2024
- RUYUAN HEC PHARM CO LTDCEPActive DMF 28786 · latest filing Jan 2015
- SRINI PHARMACEUTICALS PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 33984 · latest filing Jul 2019
- TAPI NL BVNetherlandsCEPActive DMF 28819 · latest filing Nov 2017
- USV PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 38119 · latest filing Mar 2023
- VASUDHA PHARMA CHEM LTDIndiaCEPActive DMF 38211 · latest filing Mar 2023
- Viyash Scientific LtdIndiaCEP Company GMP cert on recordActive DMF 28807 · latest filing Nov 2014
- WANBURY LTDIndiaCEPActive DMF 41648 · latest filing Apr 2025
- Zakłady Farmaceutyczne Polpharma S.A.PolandCEP Company GMP cert on recordActive DMF 27661 · latest filing Oct 2013
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 28323 · latest filing Jun 2014
- ZHEJIANG JINHUA CONBA BIO-PHARM CO LTDChinaCEP Company GMP cert on recordActive DMF 38897 · latest filing Nov 2023
- Zhejiang Tianyu Pharmaceutical Co., Ltd.ChinaCEPActive DMF 39681 · latest filing Mar 2024
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)IndiaActive DMF 38122 · latest filing Mar 2023
- APISYN HEALTHCARE PRIVATE LIMITEDIndiaActive DMF 42364 · latest filing Jan 2026
- Apotex Inc.CanadaActive DMF 28922 · latest filing Dec 2014
- Chengda Pharmaceuticals Co., Ltd.ChinaActive DMF 37820 · latest filing Jan 2023
- FUXIN LONG RUI PHARMACEUTICAL CO LTDActive DMF 33793 · latest filing May 2019
- HOLIDAY LABS MEXICO SA DE CVActive DMF 32827 · latest filing May 2018
- INTERQUIM SAPeru Company GMP cert on recordActive DMF 28993 · latest filing Jan 2015
- LUPIN MANUFACTURING SOLUTIONS LTDActive DMF 28798 · latest filing Jan 2015
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 31783 · latest filing Jul 2017
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 30403 · latest filing Mar 2016
- RAKS PHARMA PVT LTDIndiaActive DMF 29066 · latest filing Mar 2015
- SHAOXING JINGXIN PHARMACEUTICALS CO LTDChinaActive DMF 36418 · latest filing Aug 2023
- SMS Pharmaceuticals limitedIndia Company GMP cert on recordActive DMF 34212 · latest filing Jun 2020
- SS PHARMA LLCIndiaActive DMF 42691 · latest filing Sept 2025
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 28816 · latest filing Mar 2015
- Tianjin Weijie Pharmaceutical Co., Ltd.ChinaActive DMF 31135 · latest filing Dec 2016
- TOPHARMAN SHANDONG CO LTDChinaActive DMF 35602 · latest filing Feb 2021
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 32374 · latest filing Jan 2018
- YUNG ZIP CHEMICAL IND CO LTDActive DMF 34264 · latest filing Nov 2019
- ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. (No. 36 Kangyang Avenue)ChinaActive DMF 39219 · latest filing Nov 2023
- ZHEJIANG SYNCOTIDE BIO-PHARMACEUTICAL CO LTDCEPActive DMF 29439 · latest filing May 2015
- IndiaCEP
- IndiaCEP
- IndiaCEP Company GMP cert on record
- ItalyCEP Company GMP cert on record
- DIJIA PHARMACEUTICAL GROUP CO LTDCEP
- IndiaCEP Company GMP cert on record
- IndiaCEP
- SpainCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- SpainCEP
- IndiaCEP Company GMP cert on record
- NOSCH LABS PRIVATE LTDCEP Company GMP cert on record
- Shaoxing Jingxin Pharmaceutical Co., Ltd.ChinaCEP
- ChinaCEP
- ZHEJIANG LEPU PHARMACEUTICAL CO., LTD.ChinaCEP
- Zhejiang Supor Pharmaceuticals Co., LtdChinaCEP Company GMP cert on record
- TITAN PHARMAPLUS PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- DONGBANG FUTURE TECH & LIFE CO., LTD.South KoreaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- MEGA FINE PHARMA PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- KRKA, d.d.SloveniaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (61)
Certificates of Suitability on the EDQM register for Rivaroxaban, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 69 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| GOLD PHARMA PRIVATE LIMITED Anakapalli District | IN | CEP 2025-554 - Rev 00 Rivaroxaban | Oct 2026 | — |
| ZHEJIANG SYNCOTIDE BIO-PHARMACEUTICAL CO., LTD. Shaoxing | CN | CEP 2021-050 - Rev 01 Rivaroxaban | Oct 2026 | Inspected Oct 2024 Belgium |
| MICRO LABS LIMITED Bengaluru | IN | CEP 2023-290 - Rev 02 Rivaroxaban, Micronised | Sept 2026 | — |
| TITAN PHARMAPLUS PRIVATE LIMITED Mahad | IN | CEP 2025-240 - Rev 00 Rivaroxaban | Sept 2026 | — |
| MOEHS IBERICA S.L. Rubi | ES | CEP 2021-245 - Rev 03 Rivaroxaban, Micronised | Aug 2026 | — |
| WANBURY LIMITED Thane | IN | CEP 2025-298 - Rev 00 Rivaroxaban | Jul 2026 | — |
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2021-045 - Rev 02 Rivaroxaban, Form I | Jul 2026 | — |
| VIYASH SCIENTIFIC LIMITED Hyderabad | IN | CEP 2025-385 - Rev 02 Rivaroxaban, Process-2, RVS | Jul 2026 | — |
| CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad | IN | CEP 2024-452 - Rev 00 Rivaroxaban, Micronised | Jun 2026 | — |
| QUIMICA SINTETICA S.A. Alcala De Henares | ES | CEP 2020-405 - Rev 01 Rivaroxaban, Non-micronised and Micronised | Jun 2026 | Inspected Apr 2025 Spain |
| OPTIMUS DRUGS PRIVATE LIMITED Hyderabad | IN | CEP 2021-201 - Rev 01 Rivaroxaban | May 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2021-259 - Rev 04 Rivaroxaban, Modification-I | May 2026 | — |
| ALIVUS LIFE SCIENCES LIMITED Mumbai | IN | CEP 2022-021 - Rev 01 Rivaroxaban | May 2026 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2021-376 - Rev 01 Rivaroxaban, Process II | May 2026 | — |
| ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdanski | PL | CEP 2021-270 - Rev 04 Rivaroxaban, Non-micronised, Micronised | Apr 2026 | Inspected Jul 2026 Poland |
| CADILA PHARMACEUTICALS LIMITED Ankleshwar | IN | CEP 2025-140 - Rev 00 Rivaroxaban, Form-I | Apr 2026 | — |
| KOPRAN RESEARCH LABORATORIES LIMITED Mumbai | IN | CEP 2025-028 - Rev 00 Rivaroxaban | Apr 2026 | — |
| DONGBANG FUTURE TECH & LIFE CO., LTD. Hwaseong-Si | KR | CEP 2021-211 - Rev 01 Rivaroxaban | Mar 2026 | — |
| BAJAJ HEALTHCARE LIMITED Thane | IN | CEP 2023-085 - Rev 01 Rivaroxaban | Mar 2026 | — |
| DIJIA PHARMACEUTICAL GROUP CO., LTD. Weihai | CN | CEP 2024-174 - Rev 00 Rivaroxaban | Feb 2026 | — |
| NOSCH LABS PRIVATE LIMITED Hyderabad | IN | CEP 2022-110 - Rev 01 Rivaroxaban | Feb 2026 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2023-231 - Rev 02 Rivaroxaban | Feb 2026 | — |
| JUBILANT BIOSYS LIMITED Mysuru | IN | CEP 2021-178 - Rev 01 Rivaroxaban | Jan 2026 | — |
| ZHEJIANG JINHUA CONBA BIO-PHARM. CO., LTD. Jinhua City | CN | CEP 2024-021 - Rev 00 Rivaroxaban, Micronised | Jan 2026 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2021-017 - Rev 01 Rivaroxaban, Micronised, non-micronised | Dec 2025 | Inspected May 2026 Italy |
| AMI LIFESCIENCES PRIVATE LIMITED Vadodara | IN | CEP 2022-215 - Rev 02 Rivaroxaban | Nov 2025 | Inspected Oct 2025 Slovakia |
| Changzhou Pharmaceutical Factory Changzhou | CN | CEP 2021-252 - Rev 01 Rivaroxaban | Nov 2025 | Inspected Apr 2025 Italy |
| NIFTY LABS PRIVATE LIMITED Hyderabad | IN | CEP 2022-375 - Rev 01 Rivaroxaban | Sept 2025 | — |
| DIVI'S LABORATORIES LIMITED Hyderabad | IN | CEP 2024-266 - Rev 00 Rivaroxaban | Aug 2025 | — |
| SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. Shangyu | CN | CEP 2020-327 - Rev 02 Rivaroxaban, Micronised, non-micronised | Jul 2025 | — |
| LEE PHARMA LIMITED Hyderabad | IN | CEP 2022-339 - Rev 01 Rivaroxaban | Jul 2025 | — |
| SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Shenzhen City | CN | CEP 2024-239 - Rev 00 Rivaroxaban, Micronised | May 2025 | — |
| HIKAL LIMITED Bangalore | IN | CEP 2023-351 - Rev 00 Rivaroxaban | Apr 2025 | Inspected Nov 2025 Switzerland |
| TAPI NL B.V. Amsterdam | NL | CEP 2021-036 - Rev 02 Rivaroxaban | Mar 2025 | — |
| INDOCO REMEDIES LIMITED Mumbai | IN | CEP 2022-159 - Rev 01 Rivaroxaban, Micronised | Dec 2024 | — |
| MEHTA API PVT. LTD. Boisar | IN | CEP 2022-212 - Rev 01 Rivaroxaban | Dec 2024 | Inspected Oct 2024 Switzerland |
| MEGA FINE PHARMA PRIVATE LIMITED Mumbai | IN | CEP 2024-353 - Rev 00 Rivaroxaban, Micronised, improved Process | Dec 2024 | — |
| INTAS PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2020-178 - Rev 01 Rivaroxaban, Form-I, micronised | Nov 2024 | — |
| JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. Yichun | CN | CEP 2021-047 - Rev 02 Rivaroxaban | Nov 2024 | — |
| MEDICHEM, S.A. Sant Joan Despí | ES | CEP 2024-317 - Rev 00 Rivaroxaban, RVXN | Oct 2024 | — |
| USV PRIVATE LIMITED Mumbai | IN | CEP 2023-116 - Rev 01 Rivaroxaban, Micronised, Polymorphic Form-I | Oct 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2022-016 - Rev 00 Rivaroxaban | Aug 2024 | — |
| AMOLI ORGANICS PRIVATE LIMITED Mumbai | IN | CEP 2022-474 - Rev 00 Rivaroxaban, Form-I | Jul 2024 | — |
| COHANCE LIFESCIENCES LIMITED Mumbai | IN | CEP 2020-274 - Rev 02 Rivaroxaban | Jun 2024 | — |
| VASUDHA PHARMA CHEM LIMITED Hyderabad | IN | CEP 2022-397 - Rev 00 Rivaroxaban | Jun 2024 | — |
| MSN LABORATORIES PRIVATE LIMITED Rudraram Village | IN | CEP 2021-028 - Rev 01 Rivaroxaban, modification-I, micronised and non-micronised | Jun 2024 | — |
| MEDICHEM MANUFACTURING (MALTA) LTD. Hal Far | MT | CEP 2021-005 - Rev 01 Rivaroxaban | Jan 2024 | Inspected Nov 2023 Malta |
| KRKA, d.d., Novo mesto Novo mesto | SI | CEP 2021-231 - Rev 01 Rivaroxaban | Nov 2023 | Inspected Jul 2025 Slovenia |
| SRINI PHARMACEUTICALS PRIVATE LIMITED Choutuppal | IN | CEP 2021-466 - Rev 01 Rivaroxaban | Sept 2023 | Inspected Sept 2025 Sweden |
| MEGAFINE PHARMA (P) LIMITED Mumbai | IN | R0-CEP 2021-277 - Rev 01 Rivaroxaban | Aug 2023 | — |
| CAMBREX PROFARMACO MILANO S.R.L. Paullo | IT | R0-CEP 2022-314 - Rev 00 Rivaroxaban | Aug 2023 | — |
| BIOCON LIMITED Bengaluru | IN | R0-CEP 2022-144 - Rev 00 Rivaroxaban | Jul 2023 | — |
| ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. Shangyu | CN | R0-CEP 2021-389 - Rev 00 Rivaroxaban | Jun 2023 | — |
| ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City | CN | R0-CEP 2020-330 - Rev 01 Rivaroxaban | Mar 2023 | — |
| CIPLA LIMITED Mumbai | IN | R0-CEP 2021-278 - Rev 00 Rivaroxaban | Mar 2023 | — |
| BAYER AG Leverkusen | DE | R0-CEP 2021-090 - Rev 00 Rivaroxaban, Micronised | Feb 2023 | — |
| INNOVARE LABS PRIVATE LIMITED Visakhapatnam | IN | R0-CEP 2021-185 - Rev 00 Rivaroxaban | Jan 2023 | — |
| MOREPEN LABORATORIES LIMITED Baddi | IN | R0-CEP 2021-369 - Rev 00 Rivaroxaban | Jan 2023 | — |
| ZHEJIANG LEPU PHARMACEUTICAL CO., LTD Taizhou City | CN | R0-CEP 2021-142 - Rev 00 Rivaroxaban | Nov 2022 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | R0-CEP 2020-250 - Rev 01 Rivaroxaban | Oct 2022 | — |
| RUYUAN HEC PHARM CO., LTD. Shaoguan | CN | R0-CEP 2021-029 - Rev 00 Rivaroxaban | Mar 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Rivaroxaban are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Zhejiang Charioteer Pharmaceutical Co., Ltd.China · Inactive DMF 31900 · filed Jul 2017
- Viwit Pharmaceutical Co., Ltd.China · Inactive DMF 28199 · filed Apr 2014
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (76 listed products contain Rivaroxaban). The latest listed patent expires 6 Aug 2044. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Rivaroxaban is an oral anticoagulant used to prevent and treat blood clots. It works as a direct factor Xa inhibitor, which disrupts the blood coagulation cascade.
Chemical identity
- IUPAC name
- 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide
- Canonical SMILES
- C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl
- InChIKey
- KGFYHTZWPPHNLQ-AWEZNQCLSA-N
- Synonyms
- (s)-rivaroxaban, bay-59-7939, bay59-7939, jnj-39039039, jnj39039039, xarelto
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Factor Xa Inhibitor
- Mechanism of action
- Factor Xa Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Rivaroxaban?
82 organisations hold an active US FDA Type II Drug Master File or a CEP for Rivaroxaban: Dr. Reddy's Laboratories Ltd. (India), Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), AMI LIFESCIENCES PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), Bayer AG (Germany), Biocon Limited (India) and CHANGZHOU PHARMACEUTICAL FACTORY (China), and 74 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Rivaroxaban Drug Master Files are active?
Dr. Reddy's Laboratories Ltd. (DMF 41609, 28121), Alembic Pharmaceuticals Limited (DMF 28056), ALIVUS LIFE SCIENCES LTD (DMF 28864), AMI LIFESCIENCES PRIVATE LTD (DMF 37173), APITORIA PHARMA PRIVATE LTD (DMF 29048), Bayer AG (DMF 21581), Biocon Limited (DMF 35387) and CHANGZHOU PHARMACEUTICAL FACTORY (DMF 34436) and 53 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Rivaroxaban records mean?
2 organisations have only inactive Type II DMFs for Rivaroxaban. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Rivaroxaban have a European Certificate of Suitability?
Yes. 62 organisations hold a valid CEP for Rivaroxaban on the EDQM register, including GOLD PHARMA PRIVATE LIMITED Anakapalli District (IN), ZHEJIANG SYNCOTIDE BIO-PHARMACEUTICAL CO., LTD. Shaoxing (CN), MICRO LABS LIMITED Bengaluru (IN), TITAN PHARMAPLUS PRIVATE LIMITED Mahad (IN), MOEHS IBERICA S.L. Rubi (ES) and WANBURY LIMITED Thane (IN) and 55 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Rivaroxaban?
Yes. The latest patent listed for an approved US product containing Rivaroxaban expires 6 Aug 2044, across 76 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Rivaroxaban supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Rivaroxaban?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.